{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-041553","form_type":"8-K","ticker":"SRXH","cik":"0001471727","company_name":"SRx Health Solutions, Inc.","filed_at":"2023-11-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.163608+00:00","generated_at":"2026-06-08T01:05:36.354018+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Better Choice Co. 2023 annual meeting results: all four proposals approved by stockholders","bullets":["Elected directors: Lionel Conacher, Arlene Dickinson, Gil Fronzaglia, John Word III, Michael Young (each with >12.8M votes 'for').","Approved issuance of common stock upon exercise of Alphia Second Tranche Warrant (13.9M for, 0.8M against, 14k abstain).","Ratified BDO USA as independent auditor for FY 2023 (18.4M for, 120k against, 612k abstain).","Advisory vote approved named executive officer compensation (13.8M for, 903k against, 8.8k abstain).","Turnout: 19.1M shares (59.7% of outstanding) present or represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-041553","json":"https://secwatch.observer/filing/0001493152-23-041553.json","markdown":"https://secwatch.observer/filing/0001493152-23-041553.md","text":"https://secwatch.observer/filing/0001493152-23-041553.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1471727/000149315223041553/0001493152-23-041553-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1471727/000149315223041553/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T01:05:36.354018+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3835218480e52affe06e11adc948a51c4ebf9e10","claim":"SRx Health Solutions, Inc. shareholders approved Reaffirmation of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-11-15 meeting.","evidence_excerpt":"The reaffirmation of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified, with votes as follows: FOR AGAINST ABSTAIN 18,417,460 119,791 611,901","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1471727/000149315223041553/0001493152-23-041553-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-15"}],"fact_type":"shareholder_vote"},{"claim_id":"765f44fcad4a8892d602814da08cc9c8333eef63","claim":"SRx Health Solutions, Inc. shareholders approved Approval of issuance of common stock upon exercise of the Alphia Second Tranche Warrant at the 2023-11-15 meeting.","evidence_excerpt":"The vote to approve the issuance of common stock upon exercise of the Alphia Second Tranche Warrant, was as follows: FOR AGAINST ABSTAIN BROKER NON-VOTE 13,915,282 821,350 13,971 4,398,549","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1471727/000149315223041553/0001493152-23-041553-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-15"}],"fact_type":"shareholder_vote"},{"claim_id":"82225ee110742f649168a609e5ebe406012bae09","claim":"SRx Health Solutions, Inc. shareholders approved Advisory (non-binding) approval of compensation of named executive officers at the 2023-11-15 meeting.","evidence_excerpt":"The compensation of the Company’s named executive officers was approved, on an advisory (non-binding) basis, with votes as follows: FOR AGAINST ABSTAIN BROKER NON-VOTE 13,838,601 903,204 8,798 4,398,549","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1471727/000149315223041553/0001493152-23-041553-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-15"}],"fact_type":"shareholder_vote"},{"claim_id":"c273961a0277225e60f4a21bcc223d5629c7f7ef","claim":"SRx Health Solutions, Inc. shareholders approved Election of directors at the 2023-11-15 meeting.","evidence_excerpt":"Each of the following persons was duly elected to serve as a director of the Company’s board of directors for a term expiring at the 2024 annual meeting of stockholders and until his or her successor shall have been elected and qualified or until earlier resignation, removal from office or death, with votes as follows:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1471727/000149315223041553/0001493152-23-041553-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}